Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 86137553 | 8613755 | 3 | F | 20160824 | 20120614 | 20160829 | EXP | IT-JNJFOC-20120605584 | JANSSEN | VENTRE MB, DONADONI G, RE A, SPINA M, CATTANEO C, FUMAGALLI L, ET AL. SAFETY AND ACTIVITY OF INTENSIVE SHORT-TERM CHEMOIMMUNOTHERAPY IN HIV-POSITIVE (HIV+) PATIENTS (PTS) WITH BURKITT LYMPHOMA (BL). 2011;96 (S3):126. BRUNO MV, DONADONI G, RE A, SPINA M, CATTANEO C, FUMAGALLI L, ET AL. SAFETY AND ACTIVITY OF INTENSIVE SHORT-TERM CHEMOIMMUNOTHERAPY IN HIV-POSITIVE (HIV+) PATIENTS (PTS) WITH BURKITT LYMPHOMA (BL). 18-NOV-2011;118/21 ABSTRACT 2692:1156-1157. DONADONI G, BRUNO VM, RE A, SPINA M, CATT | 0.00 | A | M | Y | 0.00000 | 20160829 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 86137553 | 8613755 | 1 | PS | DOXORUBICIN | DOXORUBICIN | 1 | Intravenous (not otherwise specified) | N | 50718 | LIPOSOME INJECTION | |||||||||
| 86137553 | 8613755 | 2 | SS | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 86137553 | 8613755 | 3 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 86137553 | 8613755 | 4 | SS | VINCRISTINE | VINCRISTINE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 86137553 | 8613755 | 5 | SS | RITUXIMAB | RITUXIMAB | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 86137553 | 8613755 | 6 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 86137553 | 8613755 | 7 | SS | VP-16 | ETOPOSIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 86137553 | 8613755 | 8 | C | UNKNOWN MEDICATION | UNSPECIFIED INGREDIENT | 1 | Intrathecal | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 86137553 | 8613755 | 1 | Burkitt's lymphoma |
| 86137553 | 8613755 | 2 | Burkitt's lymphoma |
| 86137553 | 8613755 | 3 | Burkitt's lymphoma |
| 86137553 | 8613755 | 4 | Burkitt's lymphoma |
| 86137553 | 8613755 | 5 | Burkitt's lymphoma |
| 86137553 | 8613755 | 6 | Burkitt's lymphoma |
| 86137553 | 8613755 | 7 | Burkitt's lymphoma |
| 86137553 | 8613755 | 8 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 86137553 | 8613755 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 86137553 | 8613755 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |